Blueblood Ventures Limited

BVL6

INE562S01013

Investment Banking & Brokerage Services

Delayed Bombay S.E. Other stock markets 03:30:56 29/05/2023 pm IST			5-day change	1st Jan Change
11.07 ^INR	+4.93%		-.--%	-.--%

27/05	Blueblood Ventures Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI
18/05	Pushpendra Surana Resigns as Director of Blueblood Ventures Limited	CI

BlueBlood Ventures Limited Announces Regularization of Appointment of Narsimha Kavadi as an Independent Non-Executive Director

September 04, 2019 at 01:24 pm IST

BlueBlood Ventures Limited at it's board meeting on Sept. 4, 2019 approved regularization of appointment of Narsimha Kavadi as an Independent Non-Executive Director.

Latest news about Blueblood Ventures Limited

Blueblood Ventures Limited Reports Earnings Results for the Full Year Ended March 31, 2024	27/05	CI
Pushpendra Surana Resigns as Director of Blueblood Ventures Limited	18/05	CI
Blueblood Ventures Limited Reports Earnings Results for the Half Year Ended September 30, 2023	14/11	CI
BlueBlood Ventures Limited Reports Earnings Results for the Full Year Ended March 31, 2023	11/23/11	CI
BlueBlood Ventures Limited Reports Earnings Results for the Half Year Ended September 30, 2022	14/22/14	CI
BlueBlood Ventures Limited Approves Amit Kumar Lal Not Standing for Re-Election	30/22/30	CI
BlueBlood Ventures Limited Reports Earnings Results for the Full Year Ended March 31, 2022	30/22/30	CI
BlueBlood Ventures Limited Announces Appointment of Jatin Bhatia as Company Secretary and Compliance Officer	24/22/24	CI
BlueBlood Ventures Limited Announces Resignation of Palak Chopra as Company Secretary and Compliance Officer	24/22/24	CI
BlueBlood Ventures Limited Reports Earnings Results for the Half Year Ended September 30, 2021	13/21/13	CI
Blueblood Ventures Limited Reports Earnings Results for the Full Year Ended March 31, 2021	28/21/28	CI
BlueBlood Ventures Limited Announces Resignation of Raman Rastogi as Company Secretary & Compliance Officer	17/21/17	CI
BlueBlood Ventures Limited Announces Resignation of Manjeet Pugalia as Independent Director	19/21/19	CI
Blueblood Ventures Limited Announces Resignation of Neha Bansal as Company Secretary and Compliance Officer	07/20/07	CI
Blueblood Ventures Limited Reports Earnings Results for the Half Year Ended September 30, 2020	12/20/12	CI
BlueBlood Ventures Limited Announces Board Changes	04/20/04	CI
Blueblood Ventures Limited Reports Earnings Results for the Full Year Ended March 31, 2020	31/20/31	CI
Blueblood Ventures Limited Reports Earnings Results for the Half Year Ended September 30, 2019	29/19/29	CI
BlueBlood Ventures Limited Announces Regularization of Appointment of Narsimha Kavadi as an Independent Non-Executive Director	04/19/04	CI
Blueblood Ventures Limited Announces Audited Standalone Earnings Results for the Half Year and Full Year Ended March 31, 2019	29/19/29	CI
BlueBlood Ventures Limited Appoints Narsimha Kavadi as Independent Director	29/19/29	CI
600,216 Equity Shares of BlueBlood Ventures Limited are subject to a Lock-Up Agreement Ending on 3-FEB-2019.	03/19/03	CI
BlueBlood Ventures Limited cancelled the acquisition of 99.99% stake in Fullerton Securities & Wealth Advisors Limited from Angelica Investments Pte. Ltd.	16/18/16	CI
BlueBlood Ventures Limited Announces Standalone Unaudited Earnings Result for the Half Year Ended September 30, 2018	14/18/14	CI
Blueblood Ventures Limited Appoints Suresh Bohra as Chief Financial Officer	29/18/29	CI

Chart Blueblood Ventures Limited

Duration

Period

More charts

Blueblood Ventures Limited is an India-based company that is engaged in the business of security and commodity contracts brokerage, and management consultancy activities. The Company is involved in the business of equity investment and trading in equity, derivatives, currencies, venture capital funding, commodities, futures and options, as well as other financial products. The Company is also engaged in investment in real estate segment.

Sector

Investment Banking & Brokerage Services

Calendar

13/11/2024 - Q2 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Investment Banking & Brokerage Services

	1st Jan change	Capi.
BLUEBLOOD VENTURES LIMITED	-.--%	4L
MORGAN STANLEY	+4.46%	16TCr
THE GOLDMAN SACHS GROUP, INC.	+17.94%	15TCr
CHARLES SCHWAB	+5.19%	13TCr
CITIGROUP INC.	+20.37%	12TCr
CITIC SECURITIES COMPANY LIMITED	-9.52%	3.51TCr
RAYMOND JAMES FINANCIAL, INC.	+8.46%	2.51TCr
LPL FINANCIAL HOLDINGS INC.	+25.62%	2.14TCr
CSC FINANCIAL CO., LTD.	-7.83%	1.98TCr
NOMURA HOLDINGS, INC.	+54.40%	1.87TCr